ArticleThe Journal of infectious diseases2012

Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis.

Asher Maroof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.